Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Johns Hopkins receives $1.9M NIH grant to establish new center for sleep research

More than one-quarter of the adult population of the U.S. suffers from sleep disturbances known to contribute to life-threatening illnesses such as cardiovascular disease, diabetes, and dementia as well as depression, chronic pain, and fatigue. Often such sleeplessness is a consequence of obesity, lifestyle, and work.

27 Nov 2012

Word-training program found to restore key words in some dementia patients

A simple word-training program has been found to restore key words in people with a type of dementia that attacks language and our memory for words.

26 Nov 2012

Accera commences clinical efficacy trial of AC-1204 for mild-to-moderate Alzheimer's disease

Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications to address acute and chronic neurodegenerative diseases, announced today the initiation of a clinical efficacy trial examining the effects of AC-1204 in patients with mild-to-moderate Alzheimer's disease (AD).

26 Nov 2012

New therapeutic approach for preventing Alzheimer's disease

Pathological changes typical of Alzheimer's disease were significantly reduced in mice by blockade of an immune system transmitter. A research team from Charité - Universitätsmedizin Berlin and the University of Zurich has just published a new therapeutic approach in fighting Alzheimer's disease in the current issue of Nature Medicine. This approach promises potential in prevention, as well as in cases where the disease has already set in.

26 Nov 2012

Mental activities like reading and writing can preserve structural integrity in the brains of older people

Mental activities like reading and writing can preserve structural integrity in the brains of older people, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA).

26 Nov 2012

Women more likely to have gray matter atrophy prior to Alzheimer's diagnosis than men

All patients with Alzheimer's disease (AD) lose brain cells, which leads to a shrinking, or atrophy, of the brain. But the pattern of gray matter loss is significantly different in men and women, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

26 Nov 2012

People with Parkinson's benefit from exercise programs on stationary bicycles

People with Parkinson's disease benefit from exercise programs on stationary bicycles, with the greatest effect for those who pedal faster, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

26 Nov 2012

Active lifestyle helps preserve brain structure and could reduce burden of dementia, Alzheimer's

An active lifestyle helps preserve gray matter in the brains of older adults and could reduce the burden of dementia and Alzheimer's disease (AD), according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

26 Nov 2012

Turning off particular cytokines reduces Alzheimer's typical amyloid-- deposits in mice

Alzheimer's disease is one of the most common causes of dementia. In Germany and Switzerland alone, around 1.5 million people are affected, and forecasts predict a doubling of the number of patients worldwide within the next 20 years. The accumulation of particular abnormal proteins, including amyloid-- (Aβ) among others, in patients' brains plays a central role in this disease.

26 Nov 2012

New way of long-term care for elders with memory impairments

Within a stone's throw from the hustle and bustle of Route 128, a revolutionary new way to provide elder care is quietly making a difference in the town of Westwood. From the outside, the White Oak Cottages may look like ordinary, modern family homes with lots of windows and skylights but what's going on inside is anything but ordinary. Their mission is to de-institutionalize long-term care by providing a real home-like environment for those with Alzheimer's, Dementia and other cognitive impairments.

23 Nov 2012

Study to discover exactly how intravenous immune globulin treatments work

Immune globulin replacement began decades ago as a treatment for patients who could not make their own protective antibodies, but has proven to have much broader benefits than originally expected.

22 Nov 2012

Obesity and oxidative stress: an interview with Dr Elizabeth New

Even though oxygen is essential for us to live, it can react with other compounds in the body to produce molecules called free radicals, which are highly reactive and damaging.

22 Nov 2012

Six-step approach can help clinicians identify and effectively manage dementia symptoms

Behavior changes are among the most visible, disruptive and distressing symptoms of Alzheimer's disease and other dementias. From confusion, repetitive questioning and combativeness to wandering, hallucinations and loss of inhibition, the symptoms carry their own risks of injury.

22 Nov 2012

Study provides new insight into human cognitive function and risk for neurological diseases

Short snippets of DNA found in human brain tissue provide new insight into human cognitive function and risk for developing certain neurological diseases, according to researchers from the Departments of Psychiatry and Neuroscience at Mount Sinai School of Medicine. The findings are published in the November 20th issue of PLoS Biology.

22 Nov 2012

Study demonstrates memory-enhancing effects of low-level light therapy

It's called the "Silver Tsunami" - the swelling number of baby boomers surpassing age 65. As medical advancements extend their lives, they're expected to live well into their 80s and 90s - outlasting any generation in American history.

22 Nov 2012

Discovery of DKK1-WNT pathway reveals new drug targets for Alzheimer's

The discovery of the molecular pathway that drives the changes seen in the brains of Alzheimer's patients is reported today, revealing new targets for drug discovery that could be exploited to combat the disease. The study gives the most detailed understanding yet of the complex processes leading to Alzheimer's.

21 Nov 2012

MRI reveals changes in brains of people with post-concussion syndrome

MRI shows changes in the brains of people with post-concussion syndrome (PCS), according to a new study published online in the journal Radiology. Researchers hope the results point the way to improved detection and treatment for the disorder.

21 Nov 2012

Scientists extract recent drug trials to tackle Alzheimer's earlier than ever before

Alzheimer's therapeutic trials have gotten bad press lately, but it is not all gloom and doom. As evident at the 5th Clinical Trials in Alzheimer's Disease (CTAD) conference, held 29-31 October in the Principality of Monaco, scientists keep extracting new data from recent drug trials to gear up for a round of new ones that aim to tackle Alzheimer's earlier than ever before.

21 Nov 2012

Study: 2-PMPA improves cognition in mice with MS

Johns Hopkins researchers report the successful use of a form of MRI to identify what appears to be a key biochemical marker for cognitive impairment in the brains of people with multiple sclerosis (MS). In follow-up experiments on mice with a rodent form of MS, researchers were able to use an experimental compound to manipulate that same marker and dramatically improve learning and memory.

21 Nov 2012

NeuroDerm initiates enrollment in ND0612 Phase I trial for Parkinson's

NeuroDerm, Ltd. announced today that enrollment of healthy subjects is ongoing in its Phase I clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formula administered continuously via a subcutaneous delivery patch device. It is designed to provide steady levodopa blood levels and enhanced bioavailability of oral levodopa for the reduction of motor complications in Parkinson's disease.

21 Nov 2012

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Johns Hopkins receives $1.9M NIH grant to establish new center for sleep research

Word-training program found to restore key words in some dementia patients

Accera commences clinical efficacy trial of AC-1204 for mild-to-moderate Alzheimer's disease

New therapeutic approach for preventing Alzheimer's disease

Mental activities like reading and writing can preserve structural integrity in the brains of older people

Women more likely to have gray matter atrophy prior to Alzheimer's diagnosis than men

People with Parkinson's benefit from exercise programs on stationary bicycles

Active lifestyle helps preserve brain structure and could reduce burden of dementia, Alzheimer's

Turning off particular cytokines reduces Alzheimer's typical amyloid-- deposits in mice

New way of long-term care for elders with memory impairments

Study to discover exactly how intravenous immune globulin treatments work

Obesity and oxidative stress: an interview with Dr Elizabeth New

Six-step approach can help clinicians identify and effectively manage dementia symptoms

Study provides new insight into human cognitive function and risk for neurological diseases

Study demonstrates memory-enhancing effects of low-level light therapy

Discovery of DKK1-WNT pathway reveals new drug targets for Alzheimer's

MRI reveals changes in brains of people with post-concussion syndrome

Scientists extract recent drug trials to tackle Alzheimer's earlier than ever before

Study: 2-PMPA improves cognition in mice with MS

NeuroDerm initiates enrollment in ND0612 Phase I trial for Parkinson's

eBook: Neurodegeneration Therapeutics Discovery eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Neurodegeneration Therapeutics Discovery eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in